Presentation
MDD13 - Human Factors Considerations in Platform Development
DescriptionToday, injection devices, whether it being pen-injectors, autoinjectors, or wearable injection devices cover a wide range of indications, allowing patients to self-inject and take control of their treatment. As new pharmaceuticals are continuously being developed, the need for these injection devices also increases, along with the hope for better adherence and sense of control. With this, it is beneficial for manufacturing companies to develop platform injection devices, which can cater to a variety of customers, a wide user population and treatment options, rather than developing indication specific products, in order to reduce risks, save time and lower the costs. These can be novel injection devices or devices similar to those known from the market.
This poster calls for a discussion on best practice for platform development, focusing on the challenges that may occur, and the possible solutions to optimize time and effort when developing such products. How early or late should Human Factors be involved? How does/ should the approach change if the platform is like one known from the market? How can we leverage other specialists (e.g., designers) during the development of a platform product? How can different workstreams/ specialties work together collaboratively to be successful? For early and late-stage formative evaluations, as well as validation - which user groups do you include in these stages, when there is no given indication and user group yet? Is the entire user interface in scope or can some features be left out of scope until the specific conditions come into play? What are the limitations and what are the benefits? These are some of the discussion topics that arise during platform development, having to optimize the development process, whilst keeping the end users in mind.
The poster presentation will include the above points and questions, and provide examples of how these can be managed, while also inviting the audience to take part in the conversation. In doing so, the presentation will also go over the importance of having these conversations with other stakeholders and the impact that Human Factors decisions have in development. This is whether it being a new injection device or a new take on an already existing device.
This poster calls for a discussion on best practice for platform development, focusing on the challenges that may occur, and the possible solutions to optimize time and effort when developing such products. How early or late should Human Factors be involved? How does/ should the approach change if the platform is like one known from the market? How can we leverage other specialists (e.g., designers) during the development of a platform product? How can different workstreams/ specialties work together collaboratively to be successful? For early and late-stage formative evaluations, as well as validation - which user groups do you include in these stages, when there is no given indication and user group yet? Is the entire user interface in scope or can some features be left out of scope until the specific conditions come into play? What are the limitations and what are the benefits? These are some of the discussion topics that arise during platform development, having to optimize the development process, whilst keeping the end users in mind.
The poster presentation will include the above points and questions, and provide examples of how these can be managed, while also inviting the audience to take part in the conversation. In doing so, the presentation will also go over the importance of having these conversations with other stakeholders and the impact that Human Factors decisions have in development. This is whether it being a new injection device or a new take on an already existing device.
Event Type
Poster Presentation
TimeMonday, March 254:45pm - 6:15pm CDT
LocationSalon C
Digital Health
Simulation and Education
Hospital Environments
Medical and Drug Delivery Devices
Patient Safety Research and Initiatives